Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4023901 | Journal Français d'Ophtalmologie | 2012 | 5 Pages |
Abstract
This case suggests that IDI (Ozurdex®) potentiates the effect of PDT with less risk of local side-effects than triamcinolone acetonide. Further evaluation of this protocol remains necessary. Nonetheless, combined treatment with injection of IDI followed 15Â days later by PDT for the treatment of symptomatic CCH may prove to be a sound alternative to radiotherapy and may be more efficacious than PDT alone.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
L. Bazin, J. Gambrelle,